YoungJunKimMDPhD, FACS

Summary

• I hold the position of Chair, Oncology, Global Development SC at Regeneron Pharmaceuticals currently. At Vanderbilt, I was the Co-Leader of the Translational Research and Interventional Oncology Research Program at Vanderbilt Ingram Cancer Center and led the Head Neck program as a head & neck surgeon. My lab was focused on the tumor microenvironment of solid tumors with a translational goal towards development of novel immunotherapeutic modalities. My lab has made contributions in the area of tumor intrinsic STAT3 induced immunosuppression and the translation of STING agonist as an immunomodulator for cancer patients.